An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice Article

Kassa, Jiri, Karasova, Jana, Musilek, Kamil et al. (2009). An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice . 47(1), 72-76. 10.1080/15563650802043652

cited authors

  • Kassa, Jiri; Karasova, Jana; Musilek, Kamil; Kuca, Kamil; Bajgar, Jiri

sustainable development goals

authors

publication date

  • January 1, 2009

webpage

keywords

  • (E)-BUT-2-ENE LINKER
  • ANTIDOTAL TREATMENT
  • Acetylcholinesterase
  • BISPYRIDINIUM OXIME
  • CURRENTLY AVAILABLE OXIMES
  • Cyclosarin
  • H OXIMES
  • HI-6
  • IN-VIVO METHODS
  • K206
  • K269
  • Life Sciences & Biomedicine
  • Mice
  • NERVE AGENTS
  • Obidoxime
  • PARAOXON-INHIBITED ACETYLCHOLINESTERASE
  • Rats
  • Reactivation
  • SARIN
  • Science & Technology
  • Toxicology
  • VITRO

Digital Object Identifier (DOI)

publisher

  • INFORMA HEALTHCARE

start page

  • 72

end page

  • 76

volume

  • 47

issue

  • 1